BrightSpring Health Services (NASDAQ:BTSG - Get Free Report) was downgraded by research analysts at Wall Street Zen from a "strong-buy" rating to a "buy" rating in a report released on Saturday, Wall Street Zen reports.
BTSG has been the topic of several other reports. Leerink Partners boosted their target price on BrightSpring Health Services from $72.00 to $92.00 and gave the stock an "outperform" rating in a report on Monday, November 2nd. Guggenheim raised their price target on BrightSpring Health Services from $81.00 to $84.00 and gave the company a "buy" rating in a report on Tuesday, November 3rd. Zacks Research raised BrightSpring Health Services from a "hold" rating to a "strong-buy" rating in a research report on Thursday, November 5th. KeyCorp reaffirmed an "overweight" rating on shares of BrightSpring Health Services in a research report on Monday, August 3rd. Finally, UBS Group upped their price target on shares of BrightSpring Health Services from $85.00 to $92.00 and gave the stock a "buy" rating in a research note on Monday, November 2nd. Two equities research analysts have rated the stock with a Strong Buy rating and seventeen have issued a Buy rating to the company's stock. According to MarketBeat, the stock currently has a consensus rating of "Buy" and an average price target of $78.69.
Check Out Our Latest Stock Analysis on BrightSpring Health Services
BrightSpring Health Services Price Performance
BTSG stock opened at $62.84 on Friday. The firm has a 50 day moving average price of $62.62 and a 200-day moving average price of $56.75. BrightSpring Health Services has a 52-week low of $32.72 and a 52-week high of $73.75. The firm has a market capitalization of $12.50 billion, a price-to-earnings ratio of 33.97, a PEG ratio of 0.78 and a beta of 1.77. The company has a debt-to-equity ratio of 0.99, a quick ratio of 1.22 and a current ratio of 1.62.
BrightSpring Health Services (NASDAQ:BTSG - Get Free Report) last posted its quarterly earnings results on Friday, October 30th. The company reported $0.54 earnings per share for the quarter, topping the consensus estimate of $0.47 by $0.07. BrightSpring Health Services had a return on equity of 18.56% and a net margin of 2.69%. The company had revenue of $4.21 billion for the quarter, compared to the consensus estimate of $3.88 billion. The business's revenue was up 26.4% compared to the same quarter last year. Equities research analysts forecast that BrightSpring Health Services will post 1.70 EPS for the current fiscal year.
Hedge Funds Weigh In On BrightSpring Health Services
Hedge funds and other institutional investors have recently added to or reduced their stakes in the business. Root Financial Partners LLC purchased a new position in shares of BrightSpring Health Services in the third quarter worth $25,000. Allworth Financial LP purchased a new stake in shares of BrightSpring Health Services during the second quarter valued at $28,000. IFP Advisors Inc boosted its position in shares of BrightSpring Health Services by 204.5% during the second quarter. IFP Advisors Inc now owns 606 shares of the company's stock valued at $42,000 after buying an additional 407 shares during the last quarter. Kilter Group LLC bought a new stake in BrightSpring Health Services in the 2nd quarter worth about $50,000. Finally, Public Employees Retirement System of Ohio bought a new stake in BrightSpring Health Services in the 2nd quarter worth about $63,000.
About BrightSpring Health Services
(
Get Free Report)
BrightSpring Health Services is a provider of home- and community-based health services in the United States. The company supports people with complex health needs, including individuals with intellectual and developmental disabilities, behavioral health conditions, and chronic or age-related illnesses. Its services include home health and hospice care, behavioral health and rehabilitation, residential and community-based support, and pharmacy services. BrightSpring's pharmacy operations provide prescription dispensing and related services to people receiving care in homes, community settings, and long-term care facilities.
Featured Stories

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider BrightSpring Health Services, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and BrightSpring Health Services wasn't on the list.
While BrightSpring Health Services currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
The AI wave will soon hit public markets with Anthropic and OpenAI set to go public later this year. However, you don't have to wait to invest. This report shows seven AI stocks that you can buy today while the big model providers get ready to go public.
Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.
Link copied to clipboard.